ATA187480A - Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze - Google Patents

Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze

Info

Publication number
ATA187480A
ATA187480A AT0187480A AT187480A ATA187480A AT A187480 A ATA187480 A AT A187480A AT 0187480 A AT0187480 A AT 0187480A AT 187480 A AT187480 A AT 187480A AT A187480 A ATA187480 A AT A187480A
Authority
AT
Austria
Prior art keywords
producing
acid addition
addition salts
glycopeptide antibiotic
new glycopeptide
Prior art date
Application number
AT0187480A
Other languages
English (en)
Other versions
AT370130B (de
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of ATA187480A publication Critical patent/ATA187480A/de
Application granted granted Critical
Publication of AT370130B publication Critical patent/AT370130B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00—Catalysts comprising molecular sieves
    • B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28—Base exchange silicates, e.g. zeolites
    • C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00—Reforming naphtha
    • C10G35/04—Catalytic reforming
    • C10G35/06—Catalytic reforming characterised by the catalyst used
    • C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes
AT0187480A 1979-04-07 1980-04-04 Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze AT370130B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (2)

Publication Number Publication Date
ATA187480A true ATA187480A (de) 1982-07-15
AT370130B AT370130B (de) 1983-03-10

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0187480A AT370130B (de) 1979-04-07 1980-04-04 Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze

Country Status (30)

Country Link
US (2) US4303646A (de)
JP (2) JPS5697237A (de)
AR (1) AR222217A1 (de)
AT (1) AT370130B (de)
AU (2) AU533951B2 (de)
BE (1) BE882632A (de)
CA (1) CA1142866A (de)
CH (1) CH655515B (de)
DE (1) DE3013246A1 (de)
DK (1) DK149336C (de)
ES (1) ES8103170A1 (de)
FI (1) FI65630C (de)
FR (1) FR2452931A1 (de)
GR (1) GR67279B (de)
HK (1) HK23584A (de)
HU (1) HU181534B (de)
IE (1) IE49327B1 (de)
IL (1) IL59704A (de)
IT (1) IT1212411B (de)
LU (1) LU82327A1 (de)
MX (1) MX5958E (de)
NL (1) NL192989C (de)
NO (1) NO155496C (de)
NZ (1) NZ193357A (de)
PH (1) PH17230A (de)
PT (1) PT71064A (de)
SE (1) SE441188B (de)
SG (1) SG22687G (de)
YU (1) YU41917B (de)
ZA (1) ZA801629B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0046201B1 (de) 1980-08-16 1984-04-11 Gruppo Lepetit S.P.A. Antibiotikum A/16686 Faktor A2, Verfahren zu dessen Herstellung und die gleichzeitig hergestellten Antibiotika A/16686 Faktoren A1 und A3
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
AU2001245263A1 (en) * 2000-01-21 2001-07-31 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
CA2394616C (en) * 2000-10-13 2007-05-15 Ecopia Biosciences Inc. Gene cluster for ramoplanin biosynthesis
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
EP1483286A1 (de) * 2002-03-08 2004-12-08 Vicuron Pharmaceuticals, Inc. Verfahren zur herstellung derivaten von ramoplanin nahen derivaten
CA2430580A1 (en) * 2002-04-17 2003-09-04 Ecopia Biosciences Inc. Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
AU2003240545A1 (en) * 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20050043223A1 (en) * 2003-04-25 2005-02-24 Leach Timothy S. Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CA2945768A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
JPS62282579A (ja) 1987-12-08
DE3013246C2 (de) 1987-11-19
SE8002601L (sv) 1980-12-01
FI65630B (fi) 1984-02-29
IL59704A0 (en) 1980-06-30
AT370130B (de) 1983-03-10
IT8021162A0 (it) 1980-04-03
MX5958E (es) 1984-09-06
HK23584A (en) 1984-03-23
US4303646A (en) 1981-12-01
FR2452931A1 (fr) 1980-10-31
JPS6320514B2 (de) 1988-04-27
SE441188B (sv) 1985-09-16
CH655515B (de) 1986-04-30
ZA801629B (en) 1981-03-25
PH17230A (en) 1984-07-03
CA1142866A (en) 1983-03-15
AU5903680A (en) 1980-12-11
GR67279B (de) 1981-06-26
BE882632A (fr) 1980-10-03
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
DK140080A (da) 1980-10-08
NL192989C (nl) 1998-07-03
FI65630C (fi) 1984-06-11
ES490236A0 (es) 1981-02-16
IT1212411B (it) 1989-11-22
ES8103170A1 (es) 1981-02-16
FR2452931B1 (de) 1983-07-01
FI800881A (fi) 1980-10-08
JPS6251274B2 (de) 1987-10-29
IE800697L (en) 1980-10-07
JPS5697237A (en) 1981-08-05
NL8001982A (nl) 1980-10-09
US4328316A (en) 1982-05-04
YU41917B (en) 1988-02-29
AU5703680A (en) 1980-10-09
NZ193357A (en) 1982-12-07
YU93580A (en) 1983-06-30
IE49327B1 (en) 1985-09-18
NL192989B (nl) 1998-03-02
DE3013246A1 (de) 1980-10-16
AU535727B2 (en) 1984-04-05
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
SG22687G (en) 1989-07-07
HU181534B (en) 1983-10-28
AR222217A1 (es) 1981-04-30
NO155496B (no) 1986-12-29
IL59704A (en) 1983-11-30
AU533951B2 (en) 1983-12-22
DK149336B (da) 1986-05-05
DK149336C (da) 1986-10-13

Similar Documents

Publication Publication Date Title
AT386196B (de) Verfahren zur herstellung eines neuen indolderivates und seiner salze
AT370130B (de) Verfahren zur herstellung eines neuen glycopeptid-antibiotikums und seiner saeureadditionssalze
AT361142B (de) Verfahren zur herstellung eines neuen tetra- decapeptids und seiner saeureadditionssalze
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
AT374449B (de) Verfahren zur herstellung von neuen basischen aethern und deren salzen
AT382146B (de) Verfahren zur herstellung eines neuen chinolincarbonsaeurederivates und seiner salze
AT340045B (de) Verfahren zur herstellung eines neuen antibiotikumderivates und seiner saureadditionssalze
AT362059B (de) Verfahren zur herstellung eines neuen antibiotikums und seiner derivate
AT377004B (de) Verfahren zur herstellung eines neuen komplexes eines polyaether-antibiotikums
AT346479B (de) Verfahren zur herstellung eines neuen antibioticum-gemisches und seiner komponenten
AT371479B (de) Verfahren zur herstellung eines neuen kanamycin a derivates und dessen saeureadditionssalzen
AT372092B (de) Verfahren zur herstellung von neuen 3''acylierten makrolid-antibiotika und von deren salzen
AT377256B (de) Verfahren zur herstellung neuer 1-phenaethylimidazol-derivate und ihrer saeureadditionssalze
AT358725B (de) Verfahren zur herstellung eines neuen antibiotikums
ATA418082A (de) Verfahren zur herstellung eines neuen macrolid-antibiotikums
AT354645B (de) Verfahren zur herstellung eines neuen vincans und dessen salzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
AT353275B (de) Verfahren zur herstellung eines neuen benzazocinderivats und seiner saeureadditons- salze
ATA228789A (de) Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
ATA93882A (de) Verfahren zur herstellung eines neuen 3-vinyl -cephalosporins
PT70764A (de) Verfahren zur herstellung eines neuen linksdr ehenden basischen derivats des 9,10-athanoanthracens
AT376438B (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA319679A (de) Verfahren zur herstellung eines neuen, substituierten thiadiazols und dessen salze
AT377266B (de) Verfahren zur herstellung von neuen 3"-acylierten makrolid-antibiotika
AT362061B (de) Verfahren zur herstellung eines neuen antibiotikums

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELA Expired due to lapse of time